Relapse prevention by means of paroxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy

Acta Psychiatrica Scandinavica

Volumn 94, Issue 4, 1996, Pages 241-251

  Lauritzen, L ^a   Odgaard, K ^b   Clemmesen, L ^c   Lunde, M ^a   Ohrstrom J ^d   Black, C ^d   Bech, P ^a  

^a FREDERIKSBORG GENERAL HOSPITAL   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d NOVO NORDISK A S   (Denmark)

Author keywords

electroconvulsive therapy; imipramine; major depression; paroxetine; serotonin

Indexed keywords

IMIPRAMINE; PAROXETINE; PLACEBO;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE;

EID: 0029904877     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb09856.x     Document Type: Article

References (45)

1. European Union. Guidelines on psychotropic drugs: antidepressant medical products. Eur Neuropsychopharmacology 1994: 4: 62-6.
2. BECH P. Acute therapy of depression. J Clin Psychiatry 1993: 54(Suppl. 8): 18-27.
3. BOLWIG TG. ECT: wanted and unwanted effects. Behav Brain Sci 1984: 7: 23-24.
4. SCHOU M. Prophylactic and maintenance therapy in recurrent affective disorders. In: GALLANT DM, SIMPSON GM ed. Depression: behavioural, biochemical, diagnostic and treatment concepts. New York: Spectrum Publications, 1976: 309-334.
5. OTTOSSON J-O. Use and misuse of electroconvulsive treatment. Biol Psychiatry 1985: 20: 933-946.
6. FRANK E, PRIEN RF, JARRETT RB. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry 1991: 48: 851-855.
7. BECH P. A review of the antidepressant properties of serotonin reuptake inhibitors. In: GASTPAR M, WAKELIN JS ed. Selective 5-HT reuptake inhibitors: novel or commonplace agents. Basel: Karger, 1988: 58-69.
8. BECH P. Clinical effects of selective serotonin reuptake inhibitors. In: DAHL SG, GRAM LF ed. Clinical pharmacology in psychiatry. Berlin: Springer, 1989: 81-93.
9. 3H-paroxetine binding during treatment with psychoactive drugs. Biol Psychiatry 1991: 30: 1056-1058.
10. BECH P. Rating scales for psychopathology, health status and quality of life. A compendium on documentation in accordance with the DSM-III-R and WHO systems. Berlin: Springer, 1993.
11. FINK M. Combining electroconvulsive therapy and drugs. A review of safety and efficacy. CNS Drugs 1994: 1: 370-376.
12. CLEMMESEN L, HETMAR O, BOLWIG TG. Monitored electroconvulsive therapy. Dan Med Bull 1981: 28: 193-196.
13. D'ELIA G, PERRIS C. Comparison of electroconvulsive therapy with unilateral and bilateral stimulation. In: D'ELIA G, ed. Unilateral electroconvulsive therapy. Acta Psychiatr Scand 1970: Suppl. 215: 9-29.
14. BECH P, KASTRUP M, RAFAELSEN OJ. Mini-compendium of rating scales for states of anxiety, depression, mania, and schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 1986:73 (Suppl. 326): 7-37.
15. BECH P. Cronholm-Ottosson Depression Scale. The first specific depression scale for the rating of changes during treatment. Acta Psychiatr Scand 1991: 84: 439-445.
16. Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Dis 1990: 18: 289-299.
17. STASSEN HH, DELINI-STULA A, ANGST J. Time course of improvement under antidepressant treatment. A survival-analytical approach. Eur Neuropsychopharmacology 1993: 3: 127-135.
18. BELSHER G, COSTELLO CG. Relapse after recovery from unipolar depression. A critical review. Psychol Bull 1988: 104: 84-96.
19. GROF P. Designing long-term clinical trials in affective disorders. J Affect Dis 1994: 30: 243-255.
20. ARMITAGE P. Interim analysis in clinical trials. Statistics Med 1991: 10: 925-937.
21. FERGUSON GA. Statistical analysis in psychology and education. New York: McGraw Hill, 1976.
22. NOBLER MS, SACKHEIM HA. Refractory depression and electroconvulsive therapy. In: NOLEN WA et al., ed. Refractory depression. Chichester: Wiley, 1994: 69-81.
23. GERSON SC, PLOTKIN DA, JARVIK LF. Antidepressant drug studies 1964 to 1986: empirical evidence for aging patients. J Clin Psychopharmacology 1988: 8: 311-322.
24. KELLER MB, SHAPIRO RW, LAVORI PW, WOLFE N. Recovery in major depressive disorder: analysis with the life table and regression models. Arch Gen Psychiatry 1982: 39: 905-910.
25. KELLER MB, LAVORI PM, LEWIS CE, KLERMAN GL. Predictions of relapse in major depressive disorder. JAMA 1983: 250: 3299-3304.
26. HARRIS RE, MION LC, PATTERSON MB, FRENGLEY JD. Severe illness in older patients: the association between depressive disorders and functional dependency during the recovery phase. J Am Geriatr Soc 1988: 36: 890-896.
27. JARVIE H. Prognosis of depression treated by electric convulsion therapy. Br Med J 1954: 1: 132-134.
28. SEAGER CP, BIRD RL. Imipramine with electrical treatment in depression: a controlled trial. J Ment Sci 1962: 108: 704-707.
29. IMLAH NW, RYAN E, HARRINGTON JA. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 1965: 4: 438-442.
30. SACKHEIM HA, PRUDIC J, DEVANAND DP. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacology 1990: 10: 96-104.
31. COSTA D, PREDESCU V, VISAN-IONESCU I, CIUREZU T. Endogenous depression and imipramine levels in the blood. Psychopharmacology 1980: 70: 291-294.
32. FRANK E, KUPFER DJ, PEREL JM et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990: 47: 1093-1099.
33. KUPFER DJ, FRANK E, PEREL JM et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992: 49: 796-773.
34. LAURITZEN L., CLEMMESEN L., KLYSNER R. et al. Combined treatment with imipramine and mianserin. A controlled pilot study. Pharmacopsychiatry 1992: 4: 182-186.
35. PRIEN RF, KUPFER DJ, MAUSKY PA et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984: 41: 1096-1104.
36. ERIC L. A prospective double-blind comparative multicentre study of paroxetine in preventing recurrent major depressive episodes. Biol Psychiatry 1991: 29: 11-14.
37. BECH P, RASMUSSEN S, DAHL A, LAURITZEN B, LUND K. The Withdrawal Syndrome Scale for alcohol and related psychoactive drugs. Nordic Psychiatry J 1989: 43: 291-294.
38. ANDERSON IM, TOMENSON BM. The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacology 1994: 8: 238-349.
39. LOONEN AJM, PEER PGM, SWANIKKEN GJ. Continuation and maintenance therapy with antidepressive agents. Meta-analysis of research. Pharm Weekbl Sci 1991: 13: 167-175.
40. MONROE RR. Maintenance electroconvulsive therapy. Psychiatr Clin North Am 1991: 14: 947-960.
41. MINDHAM RHS, HOWLAND C, SHEPARD M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 1973: 3: 5-17.
42. FRANK E, KUPFER DJ, PEREL JM. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Dis 1993: 27: 139-145.
43. GEORGOTAS A, MCCUE RE, COOPER TB. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989: 46: 783-786.
44. PRITCHETT JT, BERNSTEIN HJ, KELLNER CH. Combined ECT and antidepressant drug therapy. Convuls Ther 1993: 9: 256-261.
45. HARSCH HH, HADDOX JD. Electroconvulsive therapy and fluoxetine. Convuls Ther 1990: 6: 250-251.